Both vancomycin (Figures 2G–L) and Abx (Figures S3G–L) reversed the systemic glucose intolerance and IR and enhanced gluconeogenesis in iNOS−/− mice as seen by a decrease in AUC during GTT, ITT, and PTT, respectively. The gene discussed is NOS2; the disease is Glucose intolerance.